CDC Expands Recommendations for COVID-19 Booster
November 30, 2021
Written Dr. Rochelle Walensky
U.S. Center for Disease Control and Prevention Director
Atlanta, GA – Monday, November 29th, 2021, the U.S. Center for Disease Control and Prevention (CDC) strengthened its recommendation on booster doses for individuals who are 18 years and older.
Everyone ages 18 and older should get a booster shot either when they are 6 months after their initial Pfizer or Moderna series or 2 months after their initial J&J vaccine.
FDA approves Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Children 5 -11
October 29, 2021
Silver Spring, MD – Today, Friday, October 29th, 2021, the U.S. Food and Drug Administration (FDA) authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 Coronavirus to include children 5 through 11 years of age.
The authorization was based on the FDA’s thorough and transparent evaluation of the data that included input from independent advisory committee experts who overwhelmingly voted in favor of making the vaccine available to children in this age group.
Tennessee Department of Health Offering Booster Dose of Pfizer COVID-19 Vaccine
September 26, 2021
Nashville, TN – The Tennessee Department of Health has begun offering booster doses of COVID-19 Coronavirus vaccine to certain populations.
A single dose booster of the Pfizer-BioNTech COVID-19 Coronavirus vaccine can be administered for individuals who met these criteria:
FDA Approves First COVID-19 Vaccine, Pfizer-BioNTech
August 23, 2021
Silver Spring, MD – Today, Monday, August 23rd, 2021, the U.S. Food and Drug Administration (FDA) approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older.
Pfizer-BioNTech COVID-19 Vaccine
Tennessee Department of Health to begin administering Pfizer COVID-19 Vaccine to Children Ages 12 and Up
May 12, 2021
Nashville, TN – The Tennessee Department of Health has announced it will begin administering the Pfizer COVID-19 vaccine to children ages 12-15 years. This is following the decision by the Advisory Committee on Immunization Practices (ACIP) to recommend to the U.S. Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) that the Pfizer vaccine be made available to administer to children ages 12-15 years.
Pfizer COVID-19 Vaccine Approved For Ages 12 and Up
Tennessee Department of Health announces Moderna COVID-19 Vaccine to arrive next Week
December 18, 2020
Nashville, TN – The Tennessee Department of Health today announced the state expects to receive its first shipment of the Moderna COVID-19 vaccine on or around December 21st, 2020.
Tennessee expects to receive an initial allocation of a total of 115,000 doses of the Moderna COVID-19 vaccine over the next two weeks, following Emergency Use Authorization issued by the U.S. Food and Drug Administration (FDA) and recommendations released by the Advisory Committee on Immunization Practices.
COVID-19 Coronavirus Vaccine Expected to Arrive at Tennessee Health Departments Next Week
Tennessee receives first shipment of Pfizer COVID-19 Vaccination
December 14, 2020
Nashville, TN – The Tennessee Department of Health today, Monday, December 14th, 2020 announced the state has received its first shipment of the Pfizer-BioNTech COVID-19 vaccine ahead of statewide shipment on Thursday.
The state obtained an early shipment of 975 doses to hold as an emergency backup supply should any receiving hospital’s supply be damaged.
Pfizer COVID-19 Vaccine
FDA Issues Emergency Use Authorization for First COVID-19 Vaccine
December 12, 2020
Silver Spring, MD – The U.S. Food and Drug Administration issued the first emergency use authorization (EUA) for a vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 16 years of age and older.
The emergency use authorization allows the Pfizer-BioNTech COVID-19 Vaccine to be distributed in the United States.
FDA issues Emergency Use Authorization for Pfizer-BioNTech COVID-19 Vaccine.
FDA Statement on Vaccines, Related Biological Products Advisory Committee Meeting
December 11, 2020
The following is attributed to FDA Commissioner Stephen M. Hahn, M.D., and Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research.
Silver Spring, MD – Following yesterday’s positive advisory committee meeting outcome regarding the Pfizer-BioNTech COVID-19 Coronavirus vaccine, the U.S. Food and Drug Administration (FDA) has informed the sponsor that it will rapidly work toward finalization and issuance of an emergency use authorization.
COVID-19 Coronavirus
Moderna, Pfizer COVID-19 Vaccines Begin Final-Stage Testing
July 28, 2020
Washington, D.C. – “Two of the most advanced experimental coronavirus vaccines entered the pivotal phase of their studies on Monday,” Peter Loftus and Jared S. Hopkins report for The Wall Street Journal.
“The start of the pivotal Moderna vaccine trial is the latest sign that the most advanced coronavirus vaccine candidates are moving into the final stages of testing, and could be ready for wider use before year’s end if results are positive.”
